To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
On Thursday, Wolfe Research adjusted its perspective on Edwards Lifesciences (NYSE:EW) shares, downgrading its rating from Peerperform to Underperform. The firm also set a price target of $60.00 for ...
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core transcatheter aortic valve replacement market share concerns ...
Edwards Lifesciences EW is developing the most comprehensive structural heart disease portfolio post the sell-off of the Critical Care wing. The Surgical Structural Heart business is benefiting ...
Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences (EW – Research Report) today. The company’s shares closed yesterday at $71.04. Discover outperforming stocks and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF ...
Timberwolves guard Anthony Edwards is one of the NBA's brightest young stars and has one of the most magnetic personalities in all of sports. Part of what makes Edwards unique is his unfiltered ...
Tamala Edwards joined 6abc in January of 2005. She is the weekday co-anchor of Action News Mornings and is a regular co-host of Inside Story, conducting probing interviews with newsmakers like ...